Enrichment of Ly6C^hi monocytes by multiple GM-CSF injections with HBV vaccine contributes to viral clearance in a HBV mouse model

References

• WHO. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva, World Health Organization 2015.
   Google Scholar
• Seo Y, Yano Y. Short- and long-term outcome of interferon therapy for chronic hepatitis B infection. World J Gastroentero 2014; 20:13284-92; PMID:25309065; https://doi.org/10.3748/wjg.v20.i37.13284
   PubMed Web of Science ®Google Scholar
• Fung J, Lai CL, Seto WK, Yuen MF. Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B. J Antimicrob Chemother 2011; 66:2715-25; PMID:21965435; https://doi.org/10.1093/jac/dkr388
   PubMed Web of Science ®Google Scholar
• Tseng TC, Kao JH. Treating Immune-tolerant Hepatitis B. J Viral Hepat 2015; 22:77-84; PMID:25424771; https://doi.org/10.1111/jvh.12370
   PubMed Web of Science ®Google Scholar
• Wen Y, Shi Y. Alum: an old dog with new tricks. Emerging microbes & infections 2016; 5:e25; PMID:27004761; https://doi.org/10.1038/emi.2016.40
   PubMed Web of Science ®Google Scholar
• Parvez MK, Arbab AH, Al-Dosari MS, Al-Rehaily AJ. Antiviral natural products against chronic Hepatitis B: Recent developments. Curr Pharm Des 2016; 22:286-93; PMID:26561057
   PubMed Web of Science ®Google Scholar
• Hu W, Huang H, Zhang TY, Mao YY, Wang XJ, Wang SQ. CpG oligodeoxynucleotide inhibits HBV replication in a hydrodynamic injection murine model. Antivir Ther 2015; 20:289-95; PMID:25279542; https://doi.org/10.3851/IMP2870
   PubMed Web of Science ®Google Scholar
• Zhang W, Du X, Zhao G, Jin H, Kang Y, Xiao C, Liu M, Wang B. Levamisole is a potential facilitator for the activation of Th1 responses of the subunit HBV vaccination. Vaccine 2009; 27:4938-46; PMID:19549606; https://doi.org/10.1016/j.vaccine.2009.06.012
   PubMed Web of Science ®Google Scholar
• Lin C, Zhu J, Zheng Y, Chen Y, Wu Z, Chong Y, Gao Z. Effect of GM-CSF in combination with hepatitis B vaccine on revacination of healthy adult non-responders. J Infect 2010; 60:264-70; PMID:20138189; https://doi.org/10.1016/j.jinf.2010.01.011
   PubMed Web of Science ®Google Scholar
• Yu TW, Chueh HY, Tsai CC, Lin CT, Qiu JT. Novel GM-CSF-based vaccines: One small step in GM-CSF gene optimization, one giant leap for human vaccines. Human vaccines & immunotherapeutics 2016; 12:3020-8; PMID:27560197; https://doi.org/10.1080/21645515.2016.1221551
   PubMed Web of Science ®Google Scholar
• Nemunaitis J. Vaccines in cancer: GVAX, a GM-CSF gene vaccine. Expert Rev Vaccines 2005; 4:259-74; PMID:16026242; https://doi.org/10.1586/14760584.4.3.259
   PubMed Web of Science ®Google Scholar
• Hellerstein M, Xu Y, Marino T, Lu S, Yi H, Wright ER, Robinson HL. Co-expression of HIV-1 virus-like particles and granulocyte-macrophage colony stimulating factor by GEO-D03 DNA vaccine. Human vaccines & immunotherapeutics 2012; 8:1654-8; PMID:23111169; https://doi.org/10.4161/hv.21978
   PubMed Web of Science ®Google Scholar
• Clive KS, Tyler JA, Clifton GT, Holmes JP, Mittendorf EA, Ponniah S, Peoples GE. Use of GM-CSF as an adjuvant with cancer vaccines: beneficial or detrimental?. Expert Rev Vaccines 2010; 9:519-25; PMID:20450326; https://doi.org/10.1586/erv.10.40
   PubMed Web of Science ®Google Scholar
• Spearman P, Kalams S, Elizaga M, Metch B, Chiu YL, Allen M, Weinhold KJ, Ferrari G, Parker SD, McElrath MJ, et al. Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial. Vaccine 2009; 27:243-9; PMID:18996425; https://doi.org/10.1016/j.vaccine.2008.10.051
   PubMed Web of Science ®Google Scholar
• Pilla L, Patuzzo R, Rivoltini L, Maio M, Pennacchioli E, Lamaj E, Maurichi A, Massarut S, Marchianò A, Santantonio C, et al. A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patients. Cancer immunology, immunotherapy: CII 2006; 55:958-68; PMID:16215718; https://doi.org/10.1007/s00262-005-0084-8
   PubMed Web of Science ®Google Scholar
• van de Laar L, Coffer PJ, Woltman AM. Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy. Blood 2012; 119:3383-93; PMID:22323450; https://doi.org/10.1182/blood-2011-11-370130
   PubMed Web of Science ®Google Scholar
• Barone M, Maiorano E, Ladisa R, Cuomo R, Pece A, Berloco P, Caruso ML, Valentini AM, Iolascon A, Francavilla A, et al. Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice. Hepatology 2003; 37:880-6; PMID:12668981; https://doi.org/10.1053/jhep.2003.50175
   PubMed Web of Science ®Google Scholar
• Wang X, Dong A, Xiao J, Zhou X, Mi H, Xu H, Zhang J, Wang B. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice. Cellular & molecular immunology 2016; 13:850-61; PMID:26166767; https://doi.org/10.1038/cmi.2015.64
   PubMed Web of Science ®Google Scholar
• Dembek C, Protzer U. Mouse models for therapeutic vaccination against hepatitis B virus. Med Microbiol Immunol 2015; 204:95-102; PMID:25523197; https://doi.org/10.1007/s00430-014-0378-6
   PubMed Web of Science ®Google Scholar
• Bissig KD, Wieland SF, Tran P, Isogawa M, Le TT, Chisari FV, Verma IM. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clin Invest 2010; 120:924-30; PMID:20179355; https://doi.org/10.1172/JCI40094
   PubMed Web of Science ®Google Scholar
• Yang PL, Althage A, Chung J, Chisari FV. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci U S A 2002; 99:13825-30; PMID:12374864; https://doi.org/10.1073/pnas.202398599
   PubMed Web of Science ®Google Scholar
• Yang D, Liu L, Zhu D, Peng H, Su L, Fu YX, Zhang L. A mouse model for HBV immunotolerance and immunotherapy. Cellular & molecular immunology 2014; 11:71-8; PMID:24076617; https://doi.org/10.1038/cmi.2013.43
   PubMed Web of Science ®Google Scholar
• Akbar SK, Onji M. Hepatitis B virus (HBV)-transgenic mice as an investigative tool to study immunopathology during HBV infection. Int J Exp Pathol 1998; 79:279-91; PMID:10193311
   PubMed Web of Science ®Google Scholar
• Chayama K, Hayes CN, Hiraga N, Abe H, Tsuge M, Imamura M. Animal model for study of human hepatitis viruses. J Gastroenterol Hepatol 2011; 26:13-8; PMID:21175788; https://doi.org/10.1111/j.1440-1746.2010.06470.x
   PubMed Web of Science ®Google Scholar
• Huang LR, Gabel YA, Graf S, Arzberger S, Kurts C, Heikenwalder M, Knolle PA, Protzer U. Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice. Gastroenterology 2012; 142:1447-50e3; PMID:22426294; https://doi.org/10.1053/j.gastro.2012.03.006
   PubMed Web of Science ®Google Scholar
• Bian Y, Zhang Z, Sun Z, Zhao J, Zhu D, Wang Y, Fu S, Guo J, Liu L, Su L, et al. Vaccines targeting PreS1 domain overcome immune tolerance in HBV carrier mice. Hepatology. 2017; [epub ahead of print]; PMID:28445927; https://doi.org/10.1002/hep.29239.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. Lampertico P, Agarwal K, Berg T, Buti M, Janssen HLA, Papatheodoridis G, Zoulim F, Tacke F. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 2017; 67:370-398; PMID:28427875; https://doi.org/10.1016/j.jhep.2017.03.021
   PubMed Web of Science ®Google Scholar
• Singh-Jasuja H, Thiolat A, Ribon M, Boissier MC, Bessis N, Rammensee HG, Decker P. The mouse dendritic cell marker CD11c is down-regulated upon cell activation through Toll-like receptor triggering. Immunobiology 2013; 218:28-39; PMID:22445076; https://doi.org/10.1016/j.imbio.2012.01.021
   PubMed Web of Science ®Google Scholar
• Mazzone A, Ricevuti G. Leukocyte CD11/CD18 integrins: biological and clinical relevance. Haematologica 1995; 80:161-75; PMID:7628754
   PubMed Web of Science ®Google Scholar
• Sun H, Bi L, Zhou J, Zhou D, Liu Y, Jin G, Yan W. Modulation of the function of dendritic cells in adolescents with chronic HBV infection by IFN-lambda1. International journal of clinical and experimental pathology 2015; 8:1743-51; PMID:25973063
   PubMed Web of Science ®Google Scholar
• Ko HJ, Brady JL, Ryg-Cornejo V, Hansen DS, Vremec D, Shortman K, Zhan Y, Lew AM. GM-CSF-responsive monocyte-derived dendritic cells are pivotal in Th17 pathogenesis. J Immunol 2014; 192:2202-9; PMID:24489100; https://doi.org/10.4049/jimmunol.1302040
   PubMed Web of Science ®Google Scholar
• Tamoutounour S, Guilliams M, Montanana Sanchis F, Liu H, Terhorst D, Malosse C, Pollet E, Ardouin L, Luche H, Sanchez C, et al. Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity 2013; 39:925-38; PMID:24184057; https://doi.org/10.1016/j.immuni.2013.10.004
   PubMed Web of Science ®Google Scholar
• Neal LM, Knoll LJ. Toxoplasma gondii profilin promotes recruitment of Ly6Chi CCR2+ inflammatory monocytes that can confer resistance to bacterial infection. PLoS Pathog 2014; 10:e1004203; PMID:24945711; https://doi.org/10.1371/journal.ppat.1004203
   PubMed Web of Science ®Google Scholar
• Iannacone M. Hepatic effector CD8(+) T-cell dynamics. Cellular & molecular immunology 2015; 12:269-72; PMID:25242274; https://doi.org/10.1038/cmi.2014.78
   PubMed Web of Science ®Google Scholar
• Tang TJ, de Man RA, Kusters JG, Kwekkeboom J, Hop WC, van der Molen RG, Schalm SW, Janssen HL. Intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients. J Med Virol 2004; 72:215-22; PMID:14695662; https://doi.org/10.1002/jmv.10565
   PubMed Web of Science ®Google Scholar
• Iannacone M, Sitia G, Ruggeri ZM, Guidotti LG. HBV pathogenesis in animal models: recent advances on the role of platelets. J Hepatol 2007; 46:719-26; PMID:17316876; https://doi.org/10.1016/j.jhep.2007.01.007
   PubMed Web of Science ®Google Scholar
• Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4:25-36; PMID:8574849
   PubMed Web of Science ®Google Scholar
• Chu HX, Kim HA, Lee S, Broughton BRS, Drummond GR, Sobey CG. Evidence of CCR2-independent transmigration of Ly6Chi monocytes into the brain after permanent cerebral ischemia in mice. Brain Res 2016; 1637:118-27; https://doi.org/10.1016/j.brainres.2016.02.030
   PubMed Web of Science ®Google Scholar
• Zhan Y, Vega-Ramos J, Carrington EM, Villadangos JA, Lew AM, Xu Y. The inflammatory cytokine, GM-CSF, alters the developmental outcome of murine dendritic cells. Eur J Immunol 2012; 42:2889-900; PMID:22806691; https://doi.org/10.1002/eji.201242477
   PubMed Web of Science ®Google Scholar
• Yan WL, Shen KY, Tien CY, Chen YA, Liu SJ. Recent progress in GM-CSF-based cancer immunotherapy. Immunotherapy 2017; 9:347-60; PMID:28303764; https://doi.org/10.2217/imt-2016-0141
   PubMed Web of Science ®Google Scholar
• Choi HJ, Gwon YD, Jang Y, Cho Y, Heo YK, Lee HJ, Kim KC, Choi J, Lee JB, Kim YB. Effect of AcHERV-GmCSF as an Influenza Virus Vaccine Adjuvant. PLoS One 2015; 10:e0129761; PMID:26090848; https://doi.org/10.1371/journal.pone.0129761
   PubMed Web of Science ®Google Scholar
• Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011; 11:762-74; PMID:21984070; https://doi.org/10.1038/nri3070
   PubMed Web of Science ®Google Scholar
• Biswas A, Bruder D, Wolf SA, Jeron A, Mack M, Heimesaat MM, Dunay IR. Ly6C(high) monocytes control cerebral toxoplasmosis. J Immunol 2015; 194:3223-35; PMID:25710908; https://doi.org/10.4049/jimmunol.1402037
   PubMed Web of Science ®Google Scholar
• Ngo LY, Kasahara S, Kumasaka DK, Knoblaugh SE, Jhingran A, Hohl TM. Inflammatory monocytes mediate early and organ-specific innate defense during systemic candidiasis. J Infect Dis 2014; 209:109-19; PMID:23922372; https://doi.org/10.1093/infdis/jit413
   PubMed Web of Science ®Google Scholar
• Bertoletti A, Ferrari C. Adaptive immunity in HBV infection. J Hepatol 2016; 64:S71-83; PMID:27084039; https://doi.org/10.1016/j.jhep.2016.01.026
   PubMed Web of Science ®Google Scholar
• Bengsch B, Martin B, Thimme R. Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation. J Hepatol 2014; 61:1212-9; PMID:25016223; https://doi.org/10.1016/j.jhep.2014.07.005
   PubMed Web of Science ®Google Scholar
• Golden-Mason L, Palmer B, Klarquist J, Mengshol JA, Castelblanco N, Rosen HR. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J Virol 2007; 81:9249-58; PMID:17567698; https://doi.org/10.1128/JVI.00409-07
   PubMed Web of Science ®Google Scholar
• Nakamoto N, Cho H, Shaked A, Olthoff K, Valiga ME, Kaminski M, Gostick E, Price DA, Freeman GJ, Wherry EJ, et al. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog 2009; 5:e1000313; PMID:19247441; https://doi.org/10.1371/journal.ppat.1000313
   PubMed Web of Science ®Google Scholar
• Ferrari C. HBV and the immune response. Liver international: official journal of the International Association for the Study of the Liver 2015; 35(Suppl 1):121-8; PMID:25529097; https://doi.org/10.1111/liv.12749
   PubMed Web of Science ®Google Scholar
• Martin J, Bosch O, Moraleda G, Bartolome J, Quiroga JA, Carreno V. Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B. Hepatology 1993; 18:775-80; PMID:8406350
   PubMed Web of Science ®Google Scholar
• Lok AS, Pan CQ, Han SH, Trinh HN, Fessel WJ, Rodell T, Massetto B, Lin L, Gaggar A, Subramanian GM, et al. Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B. J Hepatol 2016; 65:509-16; PMID:27210427; https://doi.org/10.1016/j.jhep.2016.05.016
   PubMed Web of Science ®Google Scholar